
Guardant Health, Inc.· GH
- Price
- $179.38
- Day
- -2.03%
- Mkt Cap
- $24.07B
- 52W Range
- $55.38 – $183.51
- Volume
- 3.08M
- Beta
- 1.58

Find a company by name or ticker and open its page
Insider activity, institutional flows, and fund ownership.
Insider trading analysis comparing the latest quarter against the stock's own historical baseline.
Neutral
Routine insider selling in Q3 2026
26 sales totaling $30.7M (182.9K shares)
Share volume is at a routine pace (0.6x average)
10 different insiders sold this quarter
Buying seen in 4 of 15 quarters
Selling pace
quarter in progress, filings still arriving
Stake sold
of active insiders' holdings
Seller breadth
vs 7.7 avg per quarter
Last insider purchase
buying in 4 of 16 quarters
Institutional ownership analysis with position momentum, 13F share flow, and ownership percentage trends.
Very Bullish
Institutions accumulating in Q2 2026
13F filings cover more than 100% of shares this quarter (overlapping reports), so ownership and share-flow figures are unreliable
Strong accumulation: 512 institutions adding vs 236 reducing positions
Momentum improving from prior quarter
Net breadth
512 adding vs 236 reducing
Strong accumulation
Add / reduce ratio
in Q2 2026
New − closed
158 initiated, 47 exited
Top holders adding
largest holders with a known change
ETF and mutual fund activity breakdown showing buying vs selling funds, top fund holders, and detailed holdings.
Neutral
Mixed fund activity in Q2 2026
364 ETFs and mutual funds reporting
133 buying vs 116 selling (balanced)